The national drug control platform has even focused on "it"

Source: pharmaceutical economic news 2015-1-20 pharmaceutical bidding and procurement is coming In the discussion draft of "guiding opinions on improving centralized drug procurement in public hospitals", which has not been published, it is mentioned that the national centralized purchase price negotiation for "patented drugs and exclusively produced drugs" is to be carried out Recently, some research institutions disclosed the preliminary ideas of the national health and family Planning Commission's drug negotiation mechanism:“ Relying on the platform of the national drug supply integrated management information system, information publicity and professional negotiation team shall be realized and negotiation implementation rules and strategies shall be formulated The negotiation platform shall be the platform of the national drug supply integrated management information system or on-site negotiation At present, there are five provinces (cities) in Tianjin, Jiangsu, Zhejiang, Jiangxi and Shandong provinces (cities) where the drug centralized procurement platform is interconnected with the national drug supply guarantee integrated management information system In addition, Mao Qun'an, spokesman of the national health and Family Planning Commission, revealed at the first regular press conference in 2015 held on January 12 that improving the drug supply guarantee system is one of the key tasks of the national health and family planning work in 2015 There has been a "package" of drug price negotiations and the whole drug bidding procurement Work programme, the document is still under approval "It is a general trend to set up a chess game for national drug price management, while the establishment of the national drug supply security integrated management information system platform actually plays a role in information sharing The connection of five provinces is only the first step, and all provinces will realize the interconnection with this system in the future." In the interview, Geng Hongwu, general marketing consultant of Jiuzhoutong group, made a judgment Big data collection "there are various bidding and procurement standards in various provinces, and enterprises are tired of coping with them The root problem is that there is no unified drug procurement standard in China." Li Zhenjiang, chairman of Shenwei Pharmaceutical Co., Ltd As early as last September, the statistical information center held a technical seminar on the information exchange platform of the integrated management information system of national drug supply security The head of the center pointed out that due to the lack of a unified construction standard in the early stage, it is difficult for provincial drug procurement information platforms to realize interconnection and resource sharing at this stage, which is very unfavorable for the national level policy promotion, information-based supervision and the implementation effect evaluation of basic drug system The construction of information exchange platform aims to complete data exchange and data collection by using information technology between national and provincial drug bidding platforms Through data cleaning and warehousing, the implementation and existing problems of basic drug system and related policies and measures are studied and analyzed to provide information support for further improvement of relevant drug policies "The connection between the drug centralized purchase platform of the five provinces and the comprehensive management information system of the national drug supply guarantee is actually based on the formulation of the purchase code and other information in the previous bidding process, which unifies the drug price, product specification and so on, so as to facilitate the comparison of data." Said Geng Hongwu According to Wang Xuhua, senior marketing consultant of Beijing Xuri Boyuan management consulting company, from a macro perspective, building a national platform is conducive to relevant departments to formulate large principles, overall plans and top-level design In the future, it is a good news if drug bidding is incorporated into the comprehensive management information system of national drug supply guarantee "At present, the price of drugs in China is in chaos There are ten prices in ten provinces, and there are too many local differences After the platform is connected, the drug price will be more standardized, the hospital medication will be open and transparent, and the drug price reduction is the general trend, which is conducive to the control of medical insurance fees " "I think the main purpose of building this platform is to standardize the bidding and accumulate data for unified bidding in the future According to the current trend, the whole bidding must be a combination of left and right and the whole country." Jinxuecai, deputy general manager of Jianfeng pharmaceutical industry, said in an interview with our reporter that the national health and Family Planning Commission has always considered unified bidding nationwide, so it is necessary to make data investigation and preliminary preparation in advance Some experts said that the national drug control platform, as an information platform, will realize real-time monitoring of drugs from four major links of bidding, distribution, use and settlement after docking with provincial drug centralized procurement centers In the future, the national classified procurement, national drug price negotiation mechanism and other negotiation prices will be publicized on this platform, and the bidding Center can purchase based on this Price maintenance is difficult "According to the plan, the platform monitoring includes all links from bidding, distribution to drug settlement At present, the main reference for bidding in each province is the bid winning price If the settlement link is monitored, under the condition that the secondary price negotiation is gradually promoted, the drug price has almost become an open secret." According to cypress blue analysis, whether the second price negotiation will soon become a national unified price will bring great challenges to the price maintenance of pharmaceutical enterprises "Enterprises should have a holistic view If the whole country is linked, they should be unified and balanced in terms of price." Jin Xuecai said that if the national linkage, manufacturers should pay special attention to price maintenance Because in the past, the market scale and bidding mode of each province were different, and it was normal for prices to vary from place to place Once the national drug bidding price linkage, information collection is required to provide national data, for enterprises, sometimes it must be considered to give up In this trend, enterprises must invest more in R & D innovation "Before that, it was only a centralized regional bidding, and there was still a certain living space for enterprises When the national centralized bidding, homogenization competition is more intense, then the product does not necessarily have an advantage Once the national linkage, for enterprises with weak innovation, the impact will be greater, so we need to use product differentiation and technological innovation to gain market competitive advantage " According to the analysis of the above-mentioned enterprise personage According to the reporter, in addition to testing the drug price, the above-mentioned national drug control platform will also have a publicity system The former national health and Family Planning Commission put forward the establishment of enterprise blacklist system Jin Xuecai believes that the openness of this platform can promote more standardized behavior of the whole industry.